The next 2 prints from Marko Manev’s ‘Superhero Noir’ series via Bottleneck Gallery is “Last Son” & “God of Thunder”. They are both 13″ x 19″ Giclees and are numbered editions of 75. On sale Monday, May 13th at 12pm Eastern (9am PDT) HERE.
“Last Son” by Marko Manev. 13″ x 19″ Giclee. Ed of 75 N.
“God of Thunder” by Marko Manev. 13″ x 19″ Giclee. Ed of 75 N.
The 4th installment in the ‘Superhero Noir’ series by Marko Manev is “Caped Crusader” & “Web Slinger” via Bottleneck Gallery. They are each 13″ x 19″ Giclees with a limited edition of 75. On sale Tuesday, April 9th at approx 12pm Eastern (9am PDT) HERE.
“Caped Crusader” by Marko Manev. 13″ x 19″ Giclee. Ed of 75.
“Web Slinger” by Marko Manev. 13″ x 19″ Giclee. Ed of 75.
The 3rd installment in the ‘Superhero Noir’ series by Marko Manev is “Armored Avenger” & “Sentinel of Liberty” via Bottleneck Gallery. They are each 13″ x 19″ Giclees with a limited edition of 75. On sale Tuesday, March 19th at approx 12pm Eastern (9am PDT) HERE.
“Armored Avenger” by Marko Manev. 13″ x 19″ Giclee. Ed of 75.
“Sentinel of Liberty” by Marko Manev. 13″ x 19″ Giclee. Ed of 75.
The next 2 prints in the ‘Superhero Noir’ series by Marko Manev is “Wild Animal” & “Raging Monster” via Bottleneck Gallery. They are each 13″ x 19″ Giclees with a limited edition of 75. On sale Tuesday, February 26th at 12pm EST (9am PST) HERE.
“Wild Animal” by Marko Manev. 13″ x 19″ Giclee. Ed of 75.
“Raging Monster” by Marko Manev. 13″ x 19″ Giclee. Ed of 75.
The first two pieces released in Marko Manev’s ‘Superhero Noir’ collection will be “Sentinel of the Spaceways” and “Watchmaker” via Bottleneck Gallery. They are each 18″ x 24″ Giclee or Screenprints (TBD), each with a limited edition of 75. That’s all the details for now!
On sale Friday, February 8th at 12pm EST (9am PST) HERE.
“Sentinel of the Spaceways” by Marko Manev. 18″ x 24″ print. Ed of 75.
“Watchmaker” by Marko Manev. 18″ x 24″ print. Ed of 75.
***$1 from every order in the entire Noir series will be donated to Marko’s chosen charity, The Breast Cancer Research Foundation.